Across TCGA pan-cancer cohorts, OR8K3 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated OR8K3 data layer.
The strongest signal is observed in small cell lung cancer (SCLC), where higher OR8K3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR8K3 expression acts as an unfavorable survival marker.
SCLC are the cancer types where OR8K3 RNA most reproducibly stratifies survival.